PROPHASE LABS INC (PRPH) is a publicly traded Healthcare sector company. As of August 7, 2026, PRPH trades at $0.36 with a market cap of $0 and a P/E ratio of -0.20. PRPH moved -21.87% today. Year to date, PRPH is -69.52%; over the trailing twelve months it is -96.72%. Its 52-week range spans $0.12 to $34.28. Rallies surfaces PRPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.36 |
| Market Cap | $0 |
| P/E Ratio | -0.20 |
| EPS | $-1.78 |
| Dividend Yield | 0.30% |
| 52-Week High | $34.28 |
| 52-Week Low | $0.12 |
| Volume | 5.49M |
| Avg Volume | 0 |
| Revenue (TTM) | $5.05M |
| Net Income | $-41.70M |
| Gross Margin | 40.77% |
PRPH analyst coverage data. Average price target: $0.00.